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1. Introduction  
Acute spinal cord injury (SCI) is most commonly traumatic in origin but may also result 
from degenerative spine disease, ischemia, demyelination, inflammation, or rapidly 
expanding neoplastic, hemorrhagic, or pyogenic masses (Ghezzi et al, 2001). In the United 
States, traumatic SCI with or without bony injury has an annual incidence of 28 to 55 per 
million, with an average of 10,000 new cases a year and a prevalence of 200,000 (Sekhon & 
Fehlings, 2001). The average age at the time of injury is 32 years and the male/female ratio is 
4:1. More than half (55%) of traumatic SCI involves the cervical cord. The most common 
causes of SCI are traffic accidents (motor vehicle, bicycle, pedestrian) (40%– 50%), assault 
(10%–25%), falls (20%), work-related injuries (10%–25%), and sports/recreation-related 
injuries (10%–25%) (Cheung et al, 2002; Surkhin et al, 2000). In traumatic cervical SCI, 3-
month mortality is 20% to 21%. The independent predictors of mortality are level of cord 
injury, Glasgow Coma Scale, respiratory failure, and age. Principal causes of death are 
respiratory disorders, cardiovascular disorders, pulmonary embolism, infections, and 
suicide (Claxton et al, 1998; DeVivo et al, 1999, Yeo et al, 1998). Cardiovascular disorders are 
responsible for 40.5% of deaths, being the most common cause of mortality in patients with 
SCI (Garshick et al, 2005). 
2. Cardiovascular instability  
Cardiovascular instability is a frequent complication of SCI, especially when the upper 
thoracic or cervical cord is involved (Figure 1). Peripheral sympathetic denervation results 
in arteriolar dilation and pooling of blood in the venous compartment, while interruption 
of cardiac sympathetic innervation (T1– T4) promotes bradycardia (Figure 2) and reduces 
myocardial contractility. The autonomic nervous system modulates cardiac 
electrophysiology, and, consequently, autonomic dysfunction can lead to ventricular 
arrhythmias. Concomitantly, parasympathetic input to the heart (from the vagus nerve, 
cranial nerve [CN] X) remains intact and may frequently result in bradycardia, especially 
with cervical SCI. Less commonly, cardiac arrest has been documented. Bradycardia is 
often precipitated by tracheal stimulation (for example, during suctioning) and hypoxia 
(Mathias et al, 1976; Piepmeier et al, 1985). Reflex bradycardia and cardiac arrest occur 
due to a vago–vagal reflex. Under normal circumstances, this reflex is opposed by 
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sympathetic activity. As a compensatory response to hypoxia, a pulmonary–vagal reflex 
occurs, designed to increase respiratory rate and pulmonary inflation. However, in 
patients with SCI, compensatory sympathetic activity is eliminated, leaving 
parasympathetic activity unopposed, leading to severe bradycardia and potentially 
cardiac arrest. Studies of cardiovascular abnormalities after SCI show that as many as 
100% of patients with motor complete cervical injuries (American Spinal Injury 
Association [ASIA] grades A and B) develop bradycardia, 68% are hypotensive, 35% 
require pressors, and 16% have primary cardiac arrest. Of persons with motor incomplete 
cervical injuries (ASIA grades C and D), 35-71% develop bradycardia, but few have 
hypotension or require pressors. Among patients with thoracolumbar injuries, 13-35% 
have bradycardia (Lehmann et al, 1987; Wirth et al, 2007). Bradycardia is more frequently 
encountered in the acute phase, and is more severe in the first 2–6 weeks after trauma 
(Krassioukov et al, 2007; McKinley et al, 2006). Cardiovascular dysfunctions improve in 
time. The reasons are not well understood, but synaptic reorganization or 
hyperresponsiveness of alpha receptors may play a role (Gondim et al, 2004). 
 
 
 
 
 
 
 
 
Fig. 1. Spinal cord and level of injury. 
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Fig. 2. Sinus Bradycardia during cervical SCI. 
Cardiovascular control in acute and chronic SCI has been investigated by measuring the 
response to a variety of cardiovascular markers (blood pressure, heart rate, and plasma 
levels of norepinephrine and epinephrine) before ,during and after application of noxious 
stimuli below the level of the lesion. In acute SCI, noxious stimuli ( eg. bladder 
stimulation) caused minimal changes in heart rate and plasma norepinephrine and 
epinephrine levels. In chronic SCI, noxious stimuli induced bradycardia and elevation in 
plasma norepinephrine but not in epinephrine levels. Resting plasma norepinephrine and 
epinephrine levels in both the acute and chronic SCI were lower than in normal subjects 
(Mathias et al, 1979).  
The tilt test has been used to evaluate and delineate alterations in sympathetic 
cardiovascular compensation, which reflect the degree of autonomic dysfunction. 
Autonomic and cardiovascular responses to tilt test are blunted in persons with 
quadriplegia or paraplegia (Welch et al, 2005). Such tests could be used to noninvasively 
assess autonomic dysfunction in persons with SCI, determine the degree of sympathetic 
disruption, and assess the risk of developing cardiac arrhythmias, especially bradycardia. 
However, there are very few studies on these bedside tests upon which to solidly base 
conclusions and recommendations. 
3. Treatment  
3.1 Pharmacotherapy  
Although bradycardia after cervical SCI usually resolves within 6 to 8 weeks after injury, 
it may progress to complete heart block and cardiac arrest. As such, the acute 
management and maintenance of cardiovascular stability in these patients  may range 
from  a practical clinical chore  to a potentially lifesaving responsibility. There is limited 
data available regarding the optimal and best treatment available for symptomatic 
bradycardia in this patient population (Table 1). All data on therapeutic management of 
bradycardia secondary to cervical spinal cord injury is based on case reports, case series 
and observational studies. 
Atropine, an anticholinergic agent, is generally recommended as the first-line agent for 
bradycardia after cervical spinal cord injury. Atropine improves conduction through the 
atrioventricular (AV) node by reducing vagal tone through muscarinic receptor blockade. 
The dose ranges from 0.4 to 0.6 mg, administered intravenously every 4 hours for short-term 
therapy (Abd & Braun, 1989; Pansoori & Leesar, 2004; Piepmeier et al, 1985; Sadaka et al, 
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2010; Sakamoto et al, 2007; Schulz-Stubner, 2005; Weant et al, 2007; Whitman et al, 2008; 
Winslow et al, 1986). Atropine should be kept readily available at the bedside at all times 
with this patient population, as acute episodes of bradycardia and hypotension may occur 
suddenly and without warning in the immediate few hours and days following injury. 
 
   
Modality Route of administration Mechanism of action 
   
   
Atropine IV 
reduces vagal tone by muscarinic 
receptor blockade 
   
Dopamine IV infusion Beta1 receptors on the heart 
   
Epinephrine IV infusion Beta1 receptors on the heart 
   
Aminophylline IV 
inhibition of PDE enzyme thus 
increasing c-AMP with subsequent rise 
in catecholamines 
   
Theophylline Enteral or parenteral 
inhibition of PDE enzyme thus 
increasing c-AMP with subsequent rise 
in catecholamines 
   
Propantheline Enteral 
postganglionic parasympathetic 
acetylcholine receptor blocker 
   
Permanent 
Pacemeker 
invasive  
Table 1. Therapeutic modalities for bradycardia secondary to cervical SCI. 
Another frequently utilized category of intravenous medications includes sympathomimetic 
agents such as  Dopamine or Epinephrine  which increase heart rate through action on Beta1 
receptors in the heart. Continuous infusions of dopamine at a rate of 2 to 10 mcg/kg/min or 
epinephrine at a rate of 0.01 to 0.1 mcg/kg/min has been used in the acute setting (Abd & 
Braun, 1989; Piepmeier et al, 1985; Sadaka et al, 2010; Winslow et al, 1986). Complications 
include tachyarrythmias, angina pain, palpitations, vasoconstriction, nausea, vomiting and 
headache. 
When intermittent boluses of atropine or continuous infusions of sympathomimetic drugs 
have failed to prevent  recurrent symptomatic bradycardia, or reverse high or complete 
heart block , permanent pacemaker placement has  often been used as the next therapeutic 
alternative  (Franga et al, 2006; Ruiz-Arango et al, 2006). Cardiac pacemaker implantation is 
advocated for patients with high cervical spinal cord injuries with persistent bradycardia 
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not responding to medical management (Giloff et al,1991). However, specific criteria for 
placement of a pacemaker are not well defined. The reported number of SCI patients 
requiring a pacemaker varies from 9 to 17% (Abd & Braun, 1989; Lehmann et al, 1987). 
Complications of permanent pacemakers include infection, lead malfunction, death during 
attempted insertion, and death associated with failure to capture. 
The methylxanthine agents, including aminophylline and theophylline, have been used 
effectively for the management of refractory symptomatic bradycardia when other agents 
have failed (Pansoori & Leesar, 2004; Sadaka et al, 2010; Sakamoto et al, 2007; Schulz-
Stubner, 2005; Weant et al, 2007; Whitman et al, 2008). In addition, there are recent reports 
of methylxanthines used specifically as a successful first line treatment for bradycardia 
associated with cervical spinal cord injury. None of the patients in the case series needed a 
pacemaker placement and none of the patients developed drug related side effects 
(Sadaka et al, 2010). The proposed mechanism for the chronotropic effect of these drugs is 
via inhibition of phosphodiesterase (PDE) enzyme thus increasing the cyclic adenosine 
monophosphate with subsequent rise in catecholamines. A clear benefit of these agents is 
that they may be administered on a fixed schedule as an enteral preparation. An oral (or 
intravenous)  loading dose between 200 and 300 mg was administered in most cases with 
maintenance doses starting at 100 mg three  times daily and continued for up to 12 weeks. 
Drug serum levels were variable and differed widely among patients. The effective dose 
of theophylline resulted in serum levels that were below the therapeutic range defined in 
the literature (10-20 mcg/ml), and ofcourse below the toxic range (>25 mcg/ml). Since no 
therapeutic index for symptomatic bradycardia has been established, the methylxanthine 
dose was titrated according to clinical response.  The main side effects of these agents are 
nausea, vomiting, tremor, headache, and seizures. However, No adverse effects were 
noted in any of the reports. Nonetheless until more experience is gained with this 
modality, careful attention should be made to monitor drug levels and avoid toxicity. 
Methylxanthine has also been associated with diaphragmatic strengthening in animal 
models, another potential beneficial effect to consider in spinal cord injury patients 
(Whitman et al, 2008).  
In patients requiring long-term therapy, there are case reports of successful treatment with 
propantheline 7.5 to 30 mg every 4 to 6 hours (Abd & Braun, 1989; Winslow et al, 1986). 
Propantheline competitively blocks the action of acetylcholine at postganglionic 
parasympathetic receptors. The main side effect reported from chronic propantheline 
therapy is a reduction in gastrointestinal motility due to its anticholinergic effects. 
3.2 Anticipation, prevention & positioning  
Bradycardia and potential for cardiac arrest should be anticipated in any patient with spinal 
cord injury. Bedside care providers should be alerted to the fact that life threatening events 
occur more frequently with high spinal cord lesions.  Personnel should anticipate and 
document triggers for serious bradycardic episodes. Hyperoxygenation and ambu 
“bagging” may be helpful prior to tracheal suctioning.  Prophylactic atropine administration 
before tracheal suction, laryngoscopy, or oral intubation has been shown to minimize 
severity of events (Frankel et al, 1974; Mathias ,1976;Welphy et al, 1975). Theophylline may 
also be started at the first indication of bradycardia. Particular attention should be paid to 
other potential exacerbating factors, including rapid changes in positioning, prolonged 
recumbency, drug adverse effects, underlying infection, and hypovolemia. 
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Before moving the patient out of supine position, abdominal binder, thigh-high stockings, 
and elastic bandages to the lower extremities can be applied. These measures decrease 
venous pooling in the lower extremities and splanchnic vasculature. The patient can be 
moved slowly, from a supine position to a relatively upright position. A tilt table can be 
used to slowly bring the patient to the upright position.  
3.3 Rehabilitation measures 
Active arm exercises can be used to maintain blood pressure while the patient is on the tilt 
table (Mckinley et al, 2006). Bilaterally functional electric stimulation to lower-limb muscles, 
quadriceps, hamstrings, tibialis anterior and gastrocnemius during tilting improves 
orthostatic tolerance in patients with cervical SCI. Functional electric muscle stimulation 
during tilting maneuver, significantly increases heart rate (Chao et al, 2005). 
4. Conclusion 
Spinal cord injury is a very common and devastating disease process that can occur as a 
consequence of motor vehicle collisions, falls or other traumatic injuries. Cardiac disorders 
are common consequences following SCI. Cardiovascular disturbances are the leading 
causes of morbidity and mortality in both acute and chronic phases of SCI. Disruption of 
descendent pathways from superior centers to spinal sympathetic neurons, originating into 
the intermediolateral nuclei of T1- L2 spinal cord segments results in a reduced overall 
sympathetic activity and unopposed parasympathetic activity. As a result, the most 
common cardiac dysrrhythmia is bradycardia. There are a few well established therapeutic 
modalities (Table 1) for the treatment of bradycardia associated with cervical SCI. All 
therapeutic options are based on anecdotal reports and small retrospective reviews. 
Atropine should be kept readily available at the bedside at all times. Based on recent 
evidence with methylxanthines, we recommend further studies to establish the role of these 
agents as a first line therapy in this specific patient population. Optimal dose and duration 
of therapy need to be established. Theophylline’s use via entral route as a first line therapy 
for spinal cord injury-related bradycardia can help avoid the long term use of inotropic and 
chronotropic infusions and their associated risks and complications, as well as prevent 
and/or decrease the use of cardiac pacemaker placement and its associated procedural risks 
and complications. We further recommend the study of xanthine derivates as prophylactic 
treatment for the first 2-6 weeks of the injury based on the frequency of bradycardia in 
patients with cervical SCI which is reported to be 100%. Currently, there are no established 
guidelines regarding permanent pacemaker placement in this patient population. 
Permanent pacemaker should still be considered in patients with refractory or recurrent 
bradycardia more than two weeks after the injury. In addition, the incidence of bradycardia 
after cervical SCI may be decreased by proper prophylactic measures, cardiac exercises and 
appropriate rehabilitation. 
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